Search & Analyze
Popular Searches
Balaxi Pharmaceuticals Ltd.
Trading₹24.42
CMP₹24.42
Mkt Cap₹135 Cr
P/E95.14
P/B0.54
ROE11.68%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
95.14
P/B Ratio
0.54
EV/EBITDA
15.51
Price/Sales
0.50
Dividend Yield (%)
0.00
EPS (TTM ₹)
0.26
Book Value (₹)
45.12
ROE (%)
11.68
ROCE (%)
13.01
ROA (%)
8.82
EBITDA Margin (%)
11.01
Net Profit Margin (%)
8.57
Debt/Equity
0.22
Current Ratio
4.45
Interest Coverage
8.15
Asset Turnover
1.03
Working Capital/Sales
1.55
Core EBITDA Growth (%)
-23.46
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 23133.32 | 27938.78 | 33643.27 | 24129.44 | 29256.12 |
| Net Sales | 23133.32 | 27938.78 | 33643.27 | 24129.44 | 29256.12 |
| Total Income | 23356.06 | 28435.95 | 33906.96 | 24192.71 | 29492.26 |
| Total Expenditure | 18865.54 | 22856.45 | 27901.78 | 19675.38 | 26034.59 |
| Operating Profit | 4490.52 | 5579.5 | 6005.18 | 4517.33 | 3457.67 |
| Depreciation | 29.78 | 51.22 | 175.25 | 209.84 | 189.45 |
| Exceptional Items | — | — | — | -3829.34 | — |
| Profit Before Tax | 4432.92 | 5452.23 | 5692.23 | 201.53 | 2866.97 |
| Tax | 619.19 | 686.45 | 1095.98 | 440.23 | 359.94 |
| Profit After Tax (PAT) | 3813.73 | 4765.78 | 4596.25 | -238.7 | 2507.03 |
| EPS (₹) | 38.14 | 47.66 | 45.81 | -2.32 | 4.54 |
| Dividend Payout % | — | 5 | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1000 | 1000 | 1018.13 | 1089.78 | 1104.15 |
| Reserves | 5497.97 | 10316.41 | 16240.16 | 18669.33 | 22069.48 |
| Shareholders Funds | 6497.97 | 11316.41 | 18287.98 | 20136.39 | 23173.63 |
| Total Debt | 365.92 | 363.81 | 1162.07 | 1766.1 | 5162.44 |
| Total Liabilities | 9967.95 | 17647.06 | 23966.9 | 25834.33 | 31034.24 |
| Total Assets | 9967.95 | 17647.06 | 23966.9 | 25834.33 | 31034.24 |
| Book Value / Share | 64.9797 | 113.1641 | 169.5097 | 181.3128 | 41.9755 |
| Assets | 9967.95 | 17647.06 | 23966.9 | 25834.33 | 31034.24 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 0.31 | 3414.45 | 607.52 | 486.62 | -3500.34 |
| Investing Activities | -597.28 | -2844.83 | -1056.54 | -104.63 | -2176.38 |
| Financing Activities | 364.61 | -16.28 | 2551.26 | 3025.39 | 3387.64 |
| Net Cash Flow | -232.36 | 553.34 | 2102.24 | 3407.38 | -2289.08 |
BALAXI
₹24.42
+0%